Skip to content

A Preliminary Randomized Controlled Trial with Healthy Subjects to Validate Interviewing Procedures for Self-Understanding

A Preliminary Randomized Controlled Trial with Healthy Subjects to Validate Interviewing Procedures for Self-Understanding - A Preliminary Randomized Controlled Trial with Healthy Subjects to Validate Interviewing Procedures for Self-Understanding

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056105
Enrollment
40
Registered
2024-11-08
Start date
2024-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy control

Interventions

Content: Interviews featuring questions predicated on the EXP scale score of 3 or higher. Frequency: Once Content: Interviews featuring questions based on the EXP scale score of 2 or lower. Frequenc

Sponsors

Kansai Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals who are not presently receiving care at a psychiatric institution.

Exclusion criteria

Exclusion criteria: (1) Individuals who predominantly use a language other than their native language or Japanese in their daily activities. (2) Participants who encounter challenges when conducting semi-structured interviews. (3) Other potential subjects identified as unsuitable research participants by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Rate of occurrence of EXP scale during QOL interview

Secondary

MeasureTime frame
1. Mean change in SEIQoL-DW pre- and post-interview scores. 2. Mean change in PANAS pre- and post-interview scores. 3. Mean change in CORE-OM pre- and post-interview scores.

Countries

Japan

Contacts

Public ContactYsouke Koshikawa

Kansai Medical University Department of Neuropsychiatry

foqsj2018@gmail.com06-6992-1001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026